AlphaStocks
5.2
Consider Buy

Sabra Health Care REIT, Inc. (SBRA)

Real Estate / Health Care REITs

S&P MidCap 400

$19.48

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#39out of 105 in Real Estate

Is Sabra Health Care REIT, Inc. a Good Investment in 2026?

Sabra Health Care REIT, Inc. (SBRA) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates Sabra Health Care REIT, Inc. as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Bottom half (rank 84%). Sabra Health Care REIT, Inc. currently trades below its estimated fair value of $22, suggesting potential upside. Sabra Health Care REIT, Inc. ranks #39 out of 105 stocks in the Real Estate sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E30.6ROE5.5Market Cap5BDiv Yield6.0

Estimated Fair Value

$22.2612% below

Trading below fair value estimate. EPS grew 19% last year.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Attractive

Business quality & competitive moat

Graham

Attractive

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Caution

Bottom half (rank 84%)

Frequently Asked Questions

Is Sabra Health Care REIT, Inc. (SBRA) a good investment?
Based on AlphaStocks' composite analysis, Sabra Health Care REIT, Inc. (SBRA) scores 5.2 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading below fair value estimate. EPS grew 19% last year.
What is Sabra Health Care REIT, Inc.'s Piotroski F-Score?
Sabra Health Care REIT, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SBRA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $22, SBRA appears undervalued. The stock currently trades 12% below its estimated fair value. Trading below fair value estimate. EPS grew 19% last year.
How does SBRA compare to other Real Estate stocks?
Sabra Health Care REIT, Inc. ranks #39 out of 105 stocks in the Real Estate sector, placing it in the top 37% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about SBRA?
AlphaStocks evaluates SBRA using five proven investment models. Piotroski: Neutral; Buffett: Attractive; Graham: Attractive; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 5.2/10.

Similar Stocks

NSAPEBLAMR

Compare SBRA with

SBRA vs NSASBRA vs PEBSBRA vs LAMR

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer